Markus W. Sieger - 25 Mar 2025 Form 3 Insider Report for Rafael Holdings, Inc. (RFL)

Role
Director
Signature
/s/ Markus Sieger
Issuer symbol
RFL
Transactions as of
25 Mar 2025
Net transactions value
$0
Form type
3
Filing time
02 Apr 2025, 10:56:32 UTC
Previous filing
03 Mar 2025
Next filing
29 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RFL Class B Common Stock, par value $.01 per share 155,182 25 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RFL Stock Option (right to buy) 25 Mar 2025 Class B Common Stock 2,362 $21.16 Direct F1
holding RFL Stock Option (right to buy) 25 Mar 2025 Class B Common Stock 1,181 $3.63 Direct F1
holding RFL Stock Option (right to buy) 25 Mar 2025 Class B Common Stock 5,485 $3.63 Direct F1
holding RFL Class B Common Stock Warrant (Right to Buy) 25 Mar 2025 Class B Common Stock 352 $70.93 Direct F1
holding RFL Class B Common Stock Warrant (Right to Buy) 25 Mar 2025 Class B Common Stock 352 $184.41 Direct F1
holding RFL Class B Common Stock Warrant (Right to Buy) 25 Mar 2025 Class B Common Stock 2,644 $42.56 Direct F1
holding RFL Class B Common Stock Warrant (Right to Buy) 25 Mar 2025 Class B Common Stock 23,217 $2.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares, options and warrants set forth in this Form 3 were all received in exchange for shares, options and warrants, respectively, of Cyclo Therapeutics, Inc. ("Cyclo") common stock and upon conversion of options and warrants to purchase shares of Cyclo common stock in connection with the business combination between the Issuer and Cyclo on March 25, 2025.